sicklecellanemianews48m
Most patients free of vaso-occlusive crises for years after Casgevy dose
Most sickle cell disease patients who received the gene-editing therapy Casgevy have been free from vaso-occlusive crises for ...
sicklecellanemianews1d
The difficult reality of dealing with invisible sickle cell complications
Invisible complications of sickle cell disease can result in a lack of understanding and proper care, says columnist.
sicklecellanemianews2d
Most SCD patients given Lyfgenia in trials stay free of VOEs: New data
The majority of SCD patients given Lyfgenia in clinical trials remained free of vaso-occlusive events (VOEs) following ...
sicklecellanemianews7d
Kanglin raises $20M to advance sickle cell gene therapy KL003
Kanglin Biotechnology has raised $20 million in financing to advance the development of sickle cell gene therapy KL003.
sicklecellanemianews13d
I’m learning to manage my anxiety as a sickle cell caregiver
Columnist Sylvia Amuta works to manage her anxiety after noticing that her own stress has a negative impact on her cousin ...
sicklecellanemianews9d
Trial of gene-editing therapy into SCD’s cause opens in California
Sites in Los Angeles and near San Francisco California are enrolling people with severe SCD for a trial to test a gene ...
sicklecellanemianews15d
Blood transfusion is a lifesaving part of my sickle cell management
Columnist Oluwatosin Adesoye addresses some of the myths about blood transfusion and explains why it's important in managing ...
sicklecellanemianews16d
CBT, education both effective for sickle cell pain management
Digital cognitive behavioral therapy was as effective as pain education at easing sickle cell pain, a study reported.